Plasma copeptin levels predict disease progression and tolvaptan efficacy in autosomal dominant polycystic kidney disease

TEMPO 3:4 Investigators

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'Plasma copeptin levels predict disease progression and tolvaptan efficacy in autosomal dominant polycystic kidney disease'. Together they form a unique fingerprint.

Medicine & Life Sciences